U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Center for Drug Evaluation and Research (CDER)
  5. CDER Offices and Divisions
  6. Office of Communications - Professional Affairs and Stakeholder Engagement (PASE) Staff
  1. CDER Offices and Divisions

Professional Affairs and Stakeholder Engagement (PASE) Staff

Who We Are

The Professional Affairs and Stakeholder Engagement (PASE) Staff is CDER’s focal point for advocacy groups and professional organizations such as those representing patients and health care professionals. PASE offers two-way communication with our stakeholders on human drug-related topics through a variety of engagement and outreach activities. We are passionate in serving our stakeholders to protect, promote, and advance public health.

Request a Meeting

CDER PASE Stakeholders

Request a CDER Listening Session or Other Meeting

Request a Meeting

 

Professional organizations and advocacy groups with a drug-related focus should submit a meeting request to PASE. 

Patient organizations and advocates have many options in engaging with FDA. Learn more about FDA Patient Engagement.

Small pharmaceutical business and industry have formal meeting types and correspondence options available. Learn more by exploring the resources available from CDER Small Business and Industry Assistance.

Advocacy groups and professional organizations requesting to meet with FDA about topics that span multiple centers (e.g., drugs and devices, biologics, or tobacco, etc.) should explore meetings available with FDA’s Public Engagement Staff.

Industry sponsors, consortia, charitable foundations, academia, and other non-sponsor groups including professional organizations may find benefit in a variety of meeting types. Learn about Other Meeting Options Related to Human Drugs.

What We Do

  • Coordinate listening sessions and other meetings for advocacy groups and other professional organizations to present to CDER staff about drug-related topics.
  • Connect stakeholders with the appropriate CDER resources to meet their needs.
  • Host stakeholder calls to inform key parties of important new announcements and information from CDER.
  • Provide targeted email outreach to our stakeholders about important CDER news and information affecting their area of interest.
  • Deliver monthly insights to internal CDER staff about trending and critical drug-related issues in online forums and other digital sources.
  • Manage the Safe Use Initiative, to facilitate public and private collaborations to reduce preventable harm.
  • Lead the CDER Network of Experts (NoE) program, provided in partnership with the Center for Devices and Radiological Health (CDRH).

Contact Us

Professional Affairs and Stakeholder Engagement (PASE) Staff 
CDERPASE@fda.hhs.gov

CDER Network of Experts
CDERNetworkofExperts@fda.hhs.gov

Hillandale Building, 10001 New Hampshire Avenue, Silver Spring, MD 20993

Upcoming Meetings of Interest to CDER PASE Stakeholders

Spotlight

Resources



Back to Top